Alimera Sciences, Inc. (Alimera), a global pharmaceutical company, announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, has received approval, including a positive determination for the pricing and reimbursement, for Iluvien for the prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye from the Italian Medicines Agency, AIFA.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!